Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival

Modern Pathology

Volumn 19, Issue 8, 2006, Pages 1055-1067

  Franco, Renato ^a   Camacho, Francisca I ^b   Caleo, Alessia ^c   Staibano, Stefania ^c   Bifano, Delfina ^c   De Renzo, Amalia ^c   Tranfa, Fausto ^c   De Chiara, Anna ^a   Botti, Gerardo ^a   Merola, Roberta ^d   Diez, Ana ^b   Bonavolontà, Giulio ^c   De Rosa, Gaetano ^c   Piris, Miguel A ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

bcl10; Ocular adnexa MALT lymphomas; t(11; 18)(q21; q21); t(14; 18)(q21; q32)

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN E; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; PROTEIN BCL 10; PROTEIN P16; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; CELL SIZE; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CONTROLLED STUDY; ENZYME ACTIVITY; EYE CANCER; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE MICROARRAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL NUCLEUS; DISEASE-FREE SURVIVAL; EYE NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 33746320120     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800597     Document Type: Article

References (36)

1. Knowles DM, Jakobiec FA, McNally L, et al. Lymphoid hyperplasia and malignant lymphoma occurring in ocular adnexa (orbit, conjunctiva and eyelids) a prospective multiparametric analysis of 108 cases during 1977-1987. Hum Pathol 1990;21:959-973.
2. Knowles DM, Jakobiec FA. Ocular adnexa lymphoid neoplasms: clinical, histopathologic, electron microscopic and immunologic characteristics. Hum Pathol 1982;13:148-162.
3. Ferreri AJM, Guidoboni M, Ponzoni M, et al. Evidence for association between Chlamydia pittaci and ocular anexal lymphomas. J Natl Cancer Inst 2004;96:586-594.
4. Mannami T, Yoshino T, Oshima K, et al. Clinical, histopathological and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001;14:641-649.
5. McKelvie PA, McNab A, Francis IC, et al. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol 2001;29:387-393.
6. Thieblemont C, Berger F, Dumontet C, et al. Mucosa associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000;95:802-806.
7. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003;101:1220-1235.
8. Jaffe ES. Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J Natl Cancer Inst 2004;96:571-573.
9. Nakamura S, Yao T, Aoyagi K, et al. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 1997;79:3-11.
10. Takada S, Yoshino T, Taniwaki M, et al. Involvement of the chromosomal translocation t(11;18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B-cell lymphomas of the ocular adnexa. Evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin-fixed, paraffin-embedded specimens. Mod Pathol 2003;16:445-452.
11. Streubel B, Vinatzer U, Lamprecht A, et al. T(3;14)(p14.1;q32) involving IgH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005;19:652-658.
12. Streubel B, Lamprecht A, Dierlamm J, et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003;101:2335-2339.
13. Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal zone, B cell lymphoma of mucosa-associated lymphoid tissue originating in ocular adnexa. A multiinstitutional, retrospective review of 50 patients. Cancer 2003;98:865-871.
14. Conconi A, Martinelli A, Thiéblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-2745.
15. Ye H, Liu H, Raderer M, et al. High incidence of t(11;18) (q21;q21) in Helicobacter pylori-negative gastric MALT Lymphoma. Blood 2003;101:2547-2550.
16. Zucca E, Cavalli F. Extranodal lymphoma. Ann Oncol 2000;11(Suppl 3):219-222.
17. Saez AI, Saez AJ, Artiga MJ, et al. Building an outcome predictor model for diffuse large B-cell lymphoma. Am J Pathol 2004;164:613-622.
18. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, et al. Splenic marginal zone lymphoma. Proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 2005;106:1831-1838.
19. Zinzani P, Dirnhofer S, Sabattini E, et al. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. Haematologica 2005;90:341-347.
20. Sundram U, Kim Y, Mraz-Gernhard S, et al. Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. J Cutaneous Pathol 2005;32:227-234.
21. De Jong D, Boot H, Van Heerde P, et al. Histological grading and gastric lymphoma: pre-treatment criteria and clinical relevance. Gastroenterology 1997;112:1466-1474.
22. Ye H, Gong L, Liu H, et al. MALT lymphoma with t(14;18) (q32;q21)/iGH-MALT1 is characterized by strong cytoplasmatic MALT1 and bcl10 expression. J Pathol 2005;205:293-301.
23. Murga Penas EM, Hinz K, Roser K, et al. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/ MALT1 in MALT lymphomas. Leukemia 2003;17:2225-2229.
24. Remstein ED, Kurtin PJ, Einerson RR, et al. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia 2004;18:156-160.
25. Thieblemont C, Bastion Y, Berger F, et al. Mucosa associated lymphoid tissue gastrointestinal and non-gastrointestinal lymphoma behaviour: analysis of 108 patients. J Clin Oncol 1997;15:1624-1630.
26. Silvestri F, Pipan C, Barillari G, et al. prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Leukemia 1996;10:351-355.
27. Liu Y, Dong W, Chen L, et al. Characterization of bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB. Biochem Biophys Res Com 2004;320:1-6.
28. Ghosh S, May MJ, Kopp EB. NF-kB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
29. Johnson C, Van Antwerp D, Hope TJ. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkBalpha. EMBO J 1999;18:6682-6693.
30. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu Rev Immunol 2000;18:621-663.
31. Dierlamm J, Wlodarska I, Michaux L, et al. Genetic abnormalities in marginal zone B-cell lymphoma. Hematol Oncol 2000;18:1-13.
32. Liu H, Ye H, Dogan A, et al. T(11,18) (q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear Bcl10. Blood 2001;98:1182-1187.
33. Streubel B, Klupp Simonitsch I, Mullauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004;18:1722-1726.
34. Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11,18) (q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric lymphoma. Blood 2003;102:1012-1018.
35. Capello D, Gaidano G. Molecular pathophysiology of indolent lymphoma. Haematologica 2000;85:195-201.
36. Kuo SH, Chen LT, Yeh KH, et al. Nuclear expression of bcl10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004;22:3491-3497.